Article -> Article Details
| Title | Dyspepsia Market Professional and In-Depth Industry analysis 2023 |
|---|---|
| Category | Fitness Health --> Home Health |
| Meta Keywords | Dyspepsia Market |
| Owner | vinit |
| Description | |
| Market Research Future has starting late imparted another
examination to its wide research portfolio, which is titled as “Dyspepsia
Market Research Report – Forecast to 2023″ gives an all-around
examination the measure of market size and advancements Dyspepsia is a chronic medical condition which causes
discomfort in the upper abdomen as a result of indigestion. The stomach and the
small intestine, and sometimes the esophagus does not function properly which
is the main reason for the discomfort. Gastritis, peptic ulcers, gallstones,
stomach cancer, constipation, reduced blood flow in the intestine are other
causes for dyspepsia. Overeating, over-consumption of alcohol and smoking,
might also cause dyspepsia. The global dyspepsia market is perceived to be a
steadily growing market as per the analysis of market Research Future (MRFR). Surging prevalence of digestive diseases across the globe is
one of the prime reasons for the growth of the global dyspepsia market. The
Centers for Disease Control and Prevention estimated 14.7 Mn people in the US
to be suffering from digestive ulcers in 2016. Also, the American Cancer
Society projected 26,240 new cases of stomach cancer to be diagnosed in the
year 2018. The rise in the global geriatric population remains a significant
growth driver. The aged populace is generally more susceptible to digestive
disorders and induces high demand for diagnosis & treatment. Other factors
boosting the growth of the market include the growing occurrence of diabetes
and thyroid among the global population. Rigorous R&D activities to develop
new drugs and therapies are also likely to augur the growth of the market over
the forecast period. Unhealthy diet and a sedentary lifestyle can also be
considered as a major reason for the growth of the global dyspepsia market. Due
to the current busy lifestyle, consumers are more prone to consuming on-the-go
food items which are generally unhealthy and cause digestive disorders.
Additionally, such a situation is worsened by smoking and alcohol consumption
which favors market growth. On the flipside, the growth of the market might be
hindered by high costs associated with diagnostic tests and cut-throat
competition among market players. Segmentation The global dyspepsia market has been segmented
based on diagnosis, treatment, and end user. By diagnosis, the global dyspepsia market has been segmented
into blood tests, breath tests, stool tests, endoscopy, X-ray, CT scan, and
others. By treatment, the global dyspepsia market has been segmented
into antacids, antibiotics, h2 blockers, proton pump inhibitors (PPIs),
prokinetics, psychological therapies, and others. The antacids segment has been
further segmented into calcium carbonate, loperamide, simethicone, sodium
bicarbonate, and others. The antibiotic segment has been further segmented into
amoxicillin, clarithromycin, metronidazole, and others. The H2 blockers
segment has been further segmented into cimetidine, famotidine, nizatidine,
ranitidine, and others. The Proton pump inhibitors (PPIs) segment has been
further segmented into esomeprazole, lansoprazole, and omeprazole. Prokinetics
are categorized into bethanechol and metoclopramide. By end user, the global dyspepsia market has been segmented
into hospitals and clinics, ambulatory surgical centers, pharmacies, diagnostic
centers, and others. Regional Analysis By region, the global dyspepsia market has been segmented
into the Americas, Europe, Asia-Pacific (APAC), and the Middle East and Africa
(MEA). Competitive Landscape The notable players in the global dyspepsia market are
| |